Serdar Durdagi (Serdar Durdağı, Serdar DurdaĞi, Serdar Durdaği)

Scopus Author ID Loop profile ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 40

Top Topics

Rheumatoid Arthritis

Molecular Docking

Top Venues

Turkish journal of biology = Turk biyoloji dergisi

Chembiochem : a European journal of chemical biology

Journal of chemical information and modeling

This page only lists publications with an associated author ORCID identifier.

Publications

Ehsan Sayyah, Lalehan Oktay, Huseyin Tunc, Serdar Durdagi
Developing Dynamic Structure-Based Pharmacophore and ML-Trained QSAR Models for the Discovery of Novel Resistance-Free RET Tyrosine Kinase Inhibitors Through Extensive MD Trajectories and NRI Analysis. ChemMedChem 19 (12) (2024)
Saima Ikram, Ehsan Sayyah, Serdar Durdagi
Identifying Potential SOS1 Inhibitors via Virtual Screening of Multiple Small Molecule Libraries against KRAS-SOS1 Interaction. Chembiochem : a European journal of chemical biology 25 (12) (2024)
Saima Ikram, Ehsan Sayyah, Serdar Durdagi
Identifying Potential SOS1 Inhibitors via Virtual Screening of Multiple Small Molecule Libraries against KRAS-SOS1 Interaction. Chembiochem : a European journal of chemical biology (2024)
Saima Ikram, Ehsan Sayyah, Serdar Durdagi
Identifying Potential SOS1 Inhibitors via Virtual Screening of Multiple Small Molecule Libraries against KRAS-SOS1 Interaction. Chembiochem : a European journal of chemical biology 25 (12) (2024)
Musa Özil, Halis Türker Balaydın, Murat Şentürk, Murat Şentürk, Serdar Durdagi
Efficient, rapid, and high-yield synthesis of aryl Schiff base derivatives and their in vitro and in silico inhibition studies of hCA I, hCA II, AChE, and BuChE. Archiv der Pharmazie 357 (7) (2024)
Musa Özil, Halis Türker Balaydın, Murat Şentürk, Murat Şentürk, Serdar Durdagi
Efficient, rapid, and high-yield synthesis of aryl Schiff base derivatives and their in vitro and in silico inhibition studies of hCA I, hCA II, AChE, and BuChE. Archiv der Pharmazie 357 (7) (2024)
Musa Özil, Halis Türker Balaydın, Murat Şentürk, Murat Şentürk, Serdar Durdagi
Efficient, rapid, and high-yield synthesis of aryl Schiff base derivatives and their in vitro and in silico inhibition studies of hCA I, hCA II, AChE, and BuChE. Archiv der Pharmazie (2024)
Ehsan Sayyah, Lalehan Oktay, Huseyin Tunc, Serdar Durdagi
Developing Dynamic Structure-Based Pharmacophore and ML-Trained QSAR Models for the Discovery of Novel Resistance-Free RET Tyrosine Kinase Inhibitors Through Extensive MD Trajectories and NRI Analysis. ChemMedChem (2024)
Reşit Çakmak, Eyüp Başaran, Kader Sahin, Murat Şentürk, Serdar Durdagi
Synthesis of Novel Hydrazide-Hydrazone Compounds and In Vitro and In Silico Investigation of Their Biological Activities against AChE, BChE, and hCA I and II. ACS omega 9 (18) (2024)
Saima Ikram, Ehsan Sayyah, Serdar Durdagi
Identifying Potential SOS1 Inhibitors via Virtual Screening of Multiple Small Molecule Libraries against KRAS-SOS1 Interaction. Chembiochem : a European journal of chemical biology 25 (12) (2024)
Ehsan Sayyah, Lalehan Oktay, Huseyin Tunc, Serdar Durdagi
Developing Dynamic Structure-Based Pharmacophore and ML-Trained QSAR Models for the Discovery of Novel Resistance-Free RET Tyrosine Kinase Inhibitors Through Extensive MD Trajectories and NRI Analysis. ChemMedChem 19 (12) (2024)
Salma Ghazy, Lalehan Oktay, Serdar Durdagi
A novel algorithm for the virtual screening of extensive small molecule libraries against ERCC1/XPF protein-protein interaction for the identification of resistance-bypassing potential anticancer molecules. Turkish journal of biology = Turk biyoloji dergisi 48 (2) (2024)
Reşit Çakmak, Eyüp Başaran, Kader Sahin, Murat Şentürk, Serdar Durdagi
Synthesis of Novel Hydrazide-Hydrazone Compounds and In Vitro and In Silico Investigation of Their Biological Activities against AChE, BChE, and hCA I and II. ACS omega 9 (18) (2024)
Necati Atalay, Enver Kamil Akcan, Mehmet Gül, Esra Ayan, Ebru Destan, Fatma Betül Ertem, Nurettin Tokay, Barış Çakilkaya, Zeliş Nergiz, Gözde Karakadioğlu, Abdullah Kepceoğlu, İlkin Yapici, Bilge Tosun, Nilüfer Baldir, Günseli Yildirim, J Austin Johnson, Ömür Güven, Alaleh Shafiei, Nazlı Eylül Arslan, Merve Yilmaz, Cahine Kulakman, Seyide Seda Paydos, Zeynep Sena Çinal, Kardelen Şabanoğlu, Ayşegül Pazarçeviren, Ayşenur Yilmaz, Başak Canbay, Bengisu Aşci, Esra Kartal, Serra Tavli, Mehmet Çaliseki, Gunce Goc, Arif Mermer, Gamze Yeşilay, Sevde Altuntaş, Hiroshi Tateishi, Masami Otsuka, Mikako Fujita, Şaban Tekİn, Halilibrahim Çiftçi, Serdar Durdagi, Gizem Dinler Doganay, Ezgi Karaca, Burcu Kaplan Türköz, Burak Veli Kabasakal, Ahmet Kati, Hasan DeMirci
Cryogenic X-ray crystallographic studies of biomacromolecules at Turkish Light Source " Turkish DeLight ". Turkish journal of biology = Turk biyoloji dergisi 47 (1) (2023)
Safa Haddad, Lalehan Oktay, Ismail Erol, Kader Sahin, Serdar Durdagi
Utilizing Heteroatom Types and Numbers from Extensive Ligand Libraries to Develop Novel hERG Blocker QSAR Models Using Machine Learning-Based Classifiers. ACS omega 8 (43) (2023)
Berkay Selçuk, Ismail Erol, Serdar Durdagi, Ogün Adebali
Evolutionary association of receptor-wide amino acids with G protein-coupling selectivity in aminergic GPCRs. Life science alliance 5 (10) (2022)
Ferah Comert Onder, Nermin Kahraman, Esen Bellur Atici, Ali Cagir, Hakan Kandemir, Gizem Tatar, Tugba Taskin Tok, Goknur Kara, Bekir Karliga, Serdar Durdagi, Mehmet Ay, Bulent Ozpolat
Correction to "Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo". ACS pharmacology & translational science 4 (3) (2021)
Ismail Erol, Seyfullah Enes Kotil, Ozkan Fidan, Ahmet E Yetiman, Serdar Durdagi, Fatih Ortakci
In Silico Analysis of Bacteriocins from Lactic Acid Bacteria Against SARS-CoV-2. Probiotics and antimicrobial proteins (2021)
Serdar Durdagi, Muge Didem Orhan, Busecan Aksoydan, Şeyma ÇaliŞ, Berna Dogan, Kader Sahin, Aida Shahraki, Necla Birgül Iyison, Timucin Avşar
Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2: A Combined in silico and in vitro Study. Molecular informatics (2021)
Kubra Feyza Erol, Ebru Erol, Muge Didem Orhan, Zehra Degirmenci, Tugce Kan, Aysen Gungor, Belkis Yasa, Timucin Avşar, Yuksel Cetin, Serdar Durdagi, Mustafa Güzel
Instant determination of the artemisinin from various Artemisia annua L. extracts by LC-ESI-MS/MS and their in-silico modelling and in vitro antiviral activity studies against SARS-CoV-2. Phytochemical analysis : PCA (2021)
Aida Shahraki, Ali Işbilir, Berna Dogan, Martin J Lohse, Serdar Durdagi, Necla Birgül Iyison
Structural and Functional Characterization of Allatostatin Receptor Type-C of Thaumetopoea pityocampa, a Potential Target for Next-Generation Pest Control Agents. Journal of chemical information and modeling 61 (2) (2021)
Lalehan Oktay, Ece Erdemoğlu, İlayda Tolu, Yeşim Yumak, Ayşenur Özcan, Elif Acar, Şehriban Büyükkiliç, Alpsu Olkan, Serdar Durdagi
Binary-QSAR guided virtual screening of FDA approved drugs and compounds in clinical investigation against SARS-CoV-2 main protease. Turkish journal of biology = Turk biyoloji dergisi 45 (4) (2021)
Kader Sahin, Muge Didem Orhan, Timucin Avsar, Serdar Durdagi
Hybrid In Silico and TR-FRET-Guided Discovery of Novel BCL-2 Inhibitors. ACS pharmacology & translational science 4 (3) (2021)
Gulsah Aydin, Maide Nur Paksoy, Müge Didem Orhan, Timucin Avşar, Mine Yurtsever, Serdar Durdagi
Proposing novel MDM2 inhibitors: Combined physics-driven high-throughput virtual screening and in vitro studies. Chemical biology & drug design 96 (1) (2021)
Yasemin Ünver, Dilek ÜnlÜer, Şahin Dİrekel, Serdar Durdagi
Bis benzothiophene Schiff bases: synthesis and in silico-guided biological activity studies. Turkish journal of chemistry 44 (4) (2020)
Kader Sahin, Serdar Durdagi
Combined ligand and structure-based virtual screening approaches for identification of novel AChE inhibitors. Turkish journal of chemistry 44 (3) (2020)
Duaa Kanan, Tarek Kanan, Berna Dogan, Muge Didem Orhan, Timucin Avsar, Serdar Durdagi
An Integrated in silico Approach and in vitro Study for the Discovery of Small-Molecule USP7 Inhibitors as Potential Cancer Therapies. ChemMedChem 16 (3) (2020)
Yusuf Serhat Is, Busecan Aksoydan, Murat Senturk, Mine Yurtsever, Serdar Durdagi
Integrated Binary QSAR-Driven Virtual Screening and In Vitro Studies for Finding Novel hMAO-B-Selective Inhibitors. Journal of chemical information and modeling 60 (8) (2020)
Serdar Durdagi
Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target. Turkish journal of biology = Turk biyoloji dergisi 44 (3) (2020)
Mehmet Oguz, Asif Ali Bhatti, Murat Şentürk, Serdar Karakurt, Serdar Durdagi, Mustafa Yilmaz
Formation of the inclusion complex of water soluble fluorescent calix[4]arene and naringenin: solubility, cytotoxic effect and molecular modeling studies. Journal of biomolecular structure & dynamics 38 (13) (2019)
Dimitrios Ntountaniotis, Ioannis Andreadelis, Tahsin F Kellici, Vlasios Karageorgos, Georgios Leonis, Eirini Christodoulou, Sofia Kiriakidi, Johanna Becker-Baldus, Evgenios K Stylos, Maria V Chatziathanasiadou, Christos M Chatzigiannis, Dimitrios E Damalas, Busecan Aksoydan, Uroš Javornik, Georgia Valsami, Clemens Glaubitz, Serdar Durdagi, Νikolaos S Τhomaidis, Antonios D Kolocouris, Janez Plavec, Andreas G Tzakos, George Liapakis, Thomas Mavromoustakos
Host-Guest Interactions between Candesartan and Its Prodrug Candesartan Cilexetil in Complex with 2-Hydroxypropyl-β-cyclodextrin: On the Biological Potency for Angiotensin II Antagonism. Molecular pharmaceutics 16 (3) (2019)
Ismail Erol, Bunyemin Cosut, Serdar Durdagi
Toward Understanding the Impact of Dimerization Interfaces in Angiotensin II Type 1 Receptor. Journal of chemical information and modeling 59 (10) (2019)
Mehreen Zaka, Bilal Haider Abbasi, Serdar Durdagi
Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models. Journal of biomolecular structure & dynamics 37 (9) (2018)
Ramin Ekhteiari Salmas, Philip Seeman, Matthias Stein, Serdar Durdagi
Structural Investigation of the Dopamine-2 Receptor Agonist Bromocriptine Binding to Dimeric D2HighR and D2LowR States. Journal of chemical information and modeling 58 (4) (2018)
Yusuf Serhat Is, Serdar Durdagi, Busecan Aksoydan, Mine Yurtsever
Proposing Novel MAO-B Hit Inhibitors Using Multidimensional Molecular Modeling Approaches and Application of Binary QSAR Models for Prediction of Their Therapeutic Activity, Pharmacokinetic and Toxicity Properties. ACS chemical neuroscience 9 (7) (2018)
Ramin Ekhteiari Salmas, Philip Seeman, Busecan Aksoydan, Ismail Erol, Isik Kantarcioglu, Matthias Stein, Mine Yurtsever, Serdar Durdagi
Analysis of the Glutamate Agonist LY404,039 Binding to Nonstatic Dopamine Receptor D2 Dimer Structures and Consensus Docking. ACS chemical neuroscience 8 (6) (2017)
Anna N Bukiya, Serdar Durdagi, Sergei Noskov, Avia Rosenhouse-Dantsker
Cholesterol up-regulates neuronal G protein-gated inwardly rectifying potassium (GIRK) channel activity in the hippocampus. The Journal of biological chemistry 292 (15) (2017)
Ramin Ekhteiari Salmas, Philip Seeman, Busecan Aksoydan, Matthias Stein, Mine Yurtsever, Serdar Durdagi
Biological Insights of the Dopaminergic Stabilizer ACR16 at the Binding Pocket of Dopamine D2 Receptor. ACS chemical neuroscience 8 (4) (2017)
Ramin Ekhteiari Salmas, Mehmet Fuat Gulhan, Serdar Durdagi, Engin Sahna, Huda I Abdullah, Zeliha Selamoglu
Effects of propolis, caffeic acid phenethyl ester, and pollen on renal injury in hypertensive rat: An experimental and theoretical approach. Cell biochemistry and function 35 (6) (2017)
Ramin Ekhteiari Salmas, Yusuf Serhat Is, Serdar Durdagi, Matthias Stein, Mine Yurtsever
A QM protein-ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R). Journal of biomolecular structure & dynamics 36 (10) (2017)